GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis | MicrobiomeTrials← Back to trialsNCT07617155
GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2026-09Est. Completion: 2028-09
Enrollment target: 396 participants Locations- Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Other microbiome trials you might be interested in
Hypertriglyceridemic Acute PancreatitisAcute Pancreatitis, Hypertriglyceridemia-inducedHyperlipidemia
Background: Hypertriglyceridemia-associated acute pancreatitis (HTG-AP) has become the second most common cause of acute…
Xiamen, ChinaEst. completion Jan 18, 2028
Hypertriglyceridemia Induced Acute Pancreatitis
The severity of hypertriglyceridemia induced acute pancreatitis (HTG-AP) is closely related to the serum triglyceride (T…
Shenyang, ChinaEst. completion Dec 31, 2026